This is the text extract for April Tender Notification; Contact: Kyle Reid, browse documents here.

---

29 April 2011

TENDER RESULTS

The PHARMAC Board (or Chief Executive under Delegated Authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2009/10 Invitation to Tender, dated 4 December 2009 and the 2010/11 Invitation to Tender, dated 2 November 2010. As discussed in our 2010 tender consultation document, we intend to notify tender decisions as they are made in 2011. This change is to provide maximum notification of upcoming changes to the market, specifically to incumbent suppliers. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp.

A420205 - qA18036

Page 1 of 16

---

2009/10 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2013 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to pharmaceuticals where at least one other brand is listed.

Current subsidy and price $1.80 $3.60 $7.20 $8.50 New subsidy and price $1.98 $3.15 $7.20 $7.85 Date of listing/subsidy change for tender winning brand 1 June 2011 1 June 2011 1 June 2011 1 June 2011 Date of reference pricing of other listed brands 1 August 2011 1 August 2011 1 August 2011 1 August 2011 Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 November 2011 1 November 2011 1 November 2011 1 November 2011 LA-Morph (Douglas) LA-Morph (Douglas) LA-Morph (Douglas) LA-Morph (Douglas)

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Tab long-acting 10 mg; 10 tablets, blister Tab long-acting 30 mg; 10 tablets, blister Tab long-acting 60 mg; 10 tablets, blister Tab long-acting 100 mg; 10 tablets, blister

Sole supply brand (Supplier) Arrow-Morphine LA (Arrow) Arrow-Morphine LA (Arrow) Arrow-Morphine LA (Arrow) Arrow-Morphine LA (Arrow)

Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Tab long-acting 10 mg; 10 tablets, blister Tab long-acting 30 mg; 10 tablets, blister Tab long-acting 60 mg; 10 tablets, blister Tab long-acting 100 mg; 10 tablets, blister Hospital Supply Brand (Supplier) Arrow-Morphine LA (Arrow) Arrow-Morphine LA (Arrow) Arrow-Morphine LA (Arrow) Arrow-Morphine LA (Arrow) DV Limit 1% 1% 1% 1%

The decisions were as follows:

Chemical Name Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate

Pack price $1.98 $3.15 $7.20 $7.85

Listing date 1 June 2011 1 June 2011 1 June 2011 1 June 2011

Hospital Supply Status date 1 August 2011 1 August 2011 1 August 2011 1 August 2011

A420205 - qA18036

Page 2 of 16

---

NOTE REGARDING TENDER FOR MORPHINE SULPHATE LONG-ACTING TABLETS From 12 May 2011, the registration for morphine long-acting tablets 10 mg, 30 mg, 60 mg and 100 mg will be transferred from Douglas Pharmaceuticals to Arrow Pharmaceuticals. As notified above, the tender for morphine long-acting tablets 10 mg, 30 mg, 60 mg and 100 mg has been awarded to Arrow Pharmaceuticals and the Arrow-Morphine LA brand will be listed on 1 June 2011. Arrow will be supplying the same morphine sulphate long-acting tablets as those currently supplied by Douglas, but the packaging and brand name will change. The brand name will change from LA-Morph to Arrow-Morphine LA and Arrow will supply Arrow-Morphine LA in blister packs of 10 tablets, whereas Douglas has been supplying LA-Morph in bottles of 10 tablets.

A420205 - qA18036

Page 3 of 16

---

2010/11 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2014 Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

3. Tenders awarded to an unlisted pharmaceutical.

Presentation; Pack size and type Crm 5%; 30 g OP, tube Subsidy and price $4.20 Sole supply brand (Supplier) Lyderm (API) Listing date 1 July 2011 Sole Subsidised Supply date 1 October 2011

Chemical name Permethrin

4.

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

Current subsidy and price $7.58 New subsidy and price $6.48

The decisions were as follows:

Chemical name

Presentation; Pack size and type Tab 2.5 mg; 500 tablet, bottle Tab 5 mg; 500 tablet, bottle Eye drops 0.25%; 5 ml OP, bottle Eye drops 0.5%; 5 ml OP, bottle Soln 4%; 500 ml, bottle

Sole supply brand (Supplier) ArrowBendrofluazide (Arrow) ArrowBendrofluazide (Arrow) Betoptic S (Alcon) Betoptic (Alcon) Orion (Orion) Maxitrol (Alcon)

Date of subsidy change

Sole Subsidised Supply date

Bendrofluazide

1 July 2011

1 October 2011

Bendrofluazide Betaxolol hydrochloride Betaxolol hydrochloride Chlorhexidine gluconate

$11.75

$9.95

1 July 2011

1 October 2011

$11.80 $7.50 $7.20

$11.80 $7.50 $5.90

1 July 2011 1 July 2011 1 July 2011

1 October 2011 1 October 2011 1 October 2011

Dexamethasone Eye drops 0.1% with neomycin with neomycin and sulphate 0.35% and polymyxin B sulphate 6,000 u per ml; polymyxin B sulphate 5 ml OP, bottle

$4.50

$4.50

1 July 2011

1 October 2011

A420205 - qA18036

Page 4 of 16

---

Chemical name

Presentation; Pack size and type

Current subsidy and price

New subsidy and price

Sole supply brand (Supplier)

Date of subsidy change

Sole Subsidised Supply date

Dexamethasone Eye oint 0.1% with neomycin with neomycin and sulphate 0.35% and polymyxin B sulphate 6,000 u per g; polymyxin B sulphate 3.5 g OP, tube Dextrose Docusate sodium Docusate sodium Emulsifying ointment Inj 50%, 10 ml; 5 ampoules Cap 50 mg; 100 capsules, bottle Cap 120 mg; 100 capsules, bottle Oint BP 500 g; 500 g pot

$5.39

$5.39

Maxitrol (Alcon) Biomed (Biomed) Laxofast 50 (Arrow) Laxofast 120 (Arrow) AFT (AFT) DP Lotn HC (Douglas) Gastrosoothe (AFT) Aldara (Douglas) Sebizole (Douglas) Xylocaine Viscous (AstraZeneca) Colofac (Healthcare Logistics) Asacol (Baxter)

1 July 2011

1 October 2011

$22.75 $3.95 $5.49 $3.69

$19.50 $2.57 $3.48 $3.04

1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 October 2011 1 October 2011 1 October 2011 1 October 2011

Hydrocortisone with Lotn 1% with wool fat hydrous 3% and mineral oil; wool fat and mineral oil 250 ml bottle Hyoscine Nbutylbromide Imiquimod Ketoconazole Lignocaine hydrochloride Mebeverine hydrochloride Mesalazine Tab 10 mg; 20 tablets, blister Crm 5%; 12 sachets Shampoo 2%; 100 ml OP, bottle Viscous soln 2%; 200 ml, bottle Tab 135 mg; 90 tablets, blister Suppos 500 mg; 20 suppositories, blister

$9.95

$9.95

1 July 2011

1 October 2011

$1.62 $110.40 $3.48 $55.00

$1.48 $62.00 $3.08 $55.00

1 July 2011 1 September 2011 1 July 2011 1 July 2011

1 October 2011 1 December 2011 1 October 2011 1 October 2011

$18.00

$18.00

1 July 2011

1 October 2011

$25.20

$22.80

1 July 2011

1 October 2011

A420205 - qA18036

Page 5 of 16

---

Chemical name

Presentation; Pack size and type Inj 2.5 mg per ml, 1 ml; 50 ampoules Tab 50 mg; 100 tablets, bottle Tab 500 mg; 100 tablets, bottle Oral liq 100,000 u per ml; 24 ml OP, bottle Inj 40 mg; 1 vial Tab 0.25 mg; 100 tablets, blister Tab 1 mg; 100 tablets, blister Lotion 5%; 30 ml OP, bottle Oral drops 10%; 30 ml OP, bottle Tab 60 mg; 100 tablets, bottle Oral liq 150 mg per 10 ml; 300 ml, bottle Tab 150 mg; 250 tablets, bottle Tab 300 mg; 250 tablets, bottle Eye drops 0.3%; 5 ml OP, bottle

Current subsidy and price $150.00 $5.08 $17.60 $3.19 $8.75 $48.00 $170.00 $3.65 $3.78 $40.08 $7.95 $7.99 $10.94 $11.48

New subsidy and price $140.00 $4.17 $16.54 $3.19 $6.50 $48.00 $170.00 $3.24 $3.78 $38.90 $5.92 $6.79 $9.34 $11.48

Sole supply brand (Supplier) AstraZeneca (AstraZeneca) Apo-Nicotinic Acid (Apotex) Apo-Nicotinic Acid (Apotex) Nilstat (Sigma) Pantocid IV (API) Permax (Aspen) Permax (Aspen) A-Scabies (AFT) Coloxyl (Sigma) Mestinon (Valeant) Peptisoothe (AFT) Arrow-Ranitidine (Arrow) Arrow-Ranitidine (Arrow) Tobrex (Alcon)

Date of subsidy change

Sole Subsidised Supply date

Neostigmine Nicotinic acid Nicotinic acid Nystatin Pantoprazole Pergolide Pergolide Permethrin Poloxamer Pyridostigmine bromide Ranitidine hydrochloride Ranitidine hydrochloride Ranitidine hydrochloride Tobramycin

1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011

A420205 - qA18036

Page 6 of 16

---

Chemical name

Presentation; Pack size and type Eye oint 0.3%; 3.5 g OP, tube Inj 40 mg per ml, 2 ml; 5 vials Tab 100 mg; 100 tablets, bottle Crm 0.02%; 100 g OP, tube Oint 0.02%; 100 g OP, tube 0.1% in dental paste USP; 5 g OP, tube Eye drops 0.25%; 15 ml OP, bottle Inj 500 mg; 1 vial Tab 7.5 mg; 500 tablets, bottle

Current subsidy and price $10.45 $34.50 $128.75 $6.63 $6.69 $4.38 $8.63 $5.04 $21.02

New subsidy and price $10.45 $29.32 $126.20 $6.63 $6.69 $4.34 $8.63 $3.58 $11.90

Sole supply brand (Supplier) Tobrex (Alcon) DBL Tobramycin (Hospira) Tasmar (Valeant) Aristocort (Sigma) Aristocort (Sigma) Oracort (AFT) Enuclene (Alcon) Mylan (Mylan) Apo-Zopiclone (Apotex)

Date of subsidy change

Sole Subsidised Supply date

Tobramycin Tobramycin Tolcapone Triamcinolone acetonide Triamcinolone acetonide Triamcinolone acetonide Tyloxapol Vancomycin hydrochloride Zopiclone

1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011 1 October 2011

A420205 - qA18036

Page 7 of 16

---

5.

Tenders awarded to pharmaceuticals where at least one other brand is listed.

Date of listing/subsidy change for tender winning brand 1 October 2011 Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 March 2012 Apo-Allopurinol* (Apotex) Apo-Allopurinol** (Apotex) Synermox (Douglas) Bicalox (Douglas) Rex Medical (Rex Medical) Rex Medical (Rex Medical) Rex Medical (Rex Medical) Klamycin (Mylan) Klacid (Abbott) Klamycin (Mylan) Fintral (Douglas)

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Tab 100 mg; 1000 tablets, bottle Tab 300 mg; 500 tablets, bottle Tab 500 mg with potassium clavulanate 125 mg; 100 tablets, foil pack Tab 50 mg; 28 tablets, blister Tab 250 mg; 28 tablets, blister Tab 500 mg; 28 tablets, blister Tab 750 mg; 28 tablets, blister Tab 250 mg; 14 tablets, blister Tab 500 mg; 14 tablets, blister Tab 5 mg; 30 tablets, blister

Current subsidy and price $5.44 (per 250 tabs) $4.03 (per 100 tabs) $25.10

New subsidy and price $15.90 (per 1,000 tabs) $16.75 (per 500 tabs) $12.55

Sole supply brand (Supplier)

Date of reference pricing of other listed brands

Allopurinol

Apo-Allopurinol (Apotex) Apo-Allopurinol (Apotex) Curam (Sandoz) Bicalaccord (Arrow) Cipflox (Mylan) Cipflox (Mylan) Cipflox (Mylan)

1 December 2011

Allopurinol

1 October 2011

1 December 2011

1 March 2012

Amoxycillin clavulanate Bicalutamide Ciprofloxacin Ciprofloxacin Ciprofloxacin

1 November 2011

1 January 2012

1 April 2012

$27.10 $3.35 $4.90 $7.54 $7.75

$10.00 $2.20 $3.00 $5.15

1 September 2011 1 September 2011 1 September 2011 1 September 2011

1 November 2011 1 November 2011 1 November 2011 1 November 2011

1 February 2012 1 February 2012 1 February 2012 1 February 2012

Clarithromycin

$5.53 (per 10 tabs) $23.30 $19.20

$4.19 Apo-Clarithromycin (per 14 tabs) (Apotex) Apo-Clarithromycin (Apotex) Rex Medical (Rex Medical)

1 November 2011

1 January 2012

1 April 2012

Clarithromycin Finasteride

$10.95 $5.10

1 November 2011 1 September 2011

1 January 2012 1 November 2011

1 April 2012 1 February 2012

A420205 - qA18036

Page 8 of 16

---

Chemical Name

Presentation; Pack size and type Tab paracetamol 500 mg with codeine phosphate 8 mg; 100 tablets, blister Tab 250 mg; 28 tablets, blister Eye drops 0.25%; 5 ml OP; bottle Eye drops 0.5%; 5 ml OP; bottle

Current subsidy and price

New subsidy and price

Sole supply brand (Supplier)

Date of listing/subsidy change for tender winning brand 1 September 2011

Date of reference pricing of other listed brands

Sole Subsidised Brand (Supplier) Supply date (and affected by delisting of other reference pricing listed brands) and delisting 1 February 2012 Paracode (Arrow) Apo-Terbinafine (Apotex) Apo-Timop (Apotex) Apo-Timop (Apotex)

Paracetamol with codeine

$2.45

$2.70

Relieve (Mylan) Dr Reddy's Terbinafine (Dr Reddy’s) Arrow-Timolol (Arrow) Arrow-Timolol (Arrow)

N/A

Terbinafine

$25.50

$3.57

1 September 2011

1 November 2011

1 February 2012

Timolol maleate Timolol maleate

$2.37 $2.29

$2.08 $2.08

1 November 2011 1 November 2011

1 January 2012 1 January 2012

1 April 2012 1 April 2012

* Apotex’s 250 tablet pack size will be reference priced and delisted ** Apotex’s 100 tablet pack size will be reference priced and delisted

A420205 - qA18036

Page 9 of 16

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

6. Tenders awarded to pharmaceuticals where no brand is listed.

Presentation; Pack size and type Inj 500 mg; 1 vial Inj 50%, 50 ml; 1 bottle Inj 100 mg (of etoposide base); 1 vial Viscous soln 2%; 200 ml, bottle Tab paracetamol 500 mg with codeine phosphate 8 mg; 100 tablets, blister Crm 5%; 30 g, tube Tab 60 mg; 100 tablets, bottle Eye drops 0.3%; 5 ml, bottle Eye oint 0.3%; 3.5 g, tube Tab 100 mg; 100 tablets, bottle Hospital Supply Brand (Supplier) Klacid (Abbott) Biomed (Biomed) Etopophos (BMS) Xylocaine Viscous (AstraZeneca) Relieve (Mylan) Lyderm (API) Mestinon (Valeant) Tobrex (Alcon) Tobrex (Alcon) Tasmar (Valeant) DV Limit 1% 1%

The decisions were as follows:

Chemical Name Clarithromycin Dextrose Etoposide phosphate* Lignocaine hydrochloride Paracetamol with codeine Permethrin Pyridostigmine bromide Tobramycin Tobramycin Tolcapone

Pack price $30.00 $10.85

Listing date 1 August 2011 1 July 2011

Hospital Supply Status date 1 October 2011 1 September 2011

$40.00

1%

1 July 2011

1 September 2011

$55.00

1%

1 July 2011

1 September 2011

$2.70

1%

1 September 2011

1 November 2011

$4.20 $38.90 $11.48 $10.45 $126.20

1% 1% 1% 1% 1%

1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

* Etoposide phosphate 100 mg injection and 1 mg injection for ECP will remain listed in Section B of the Pharmaceutical as PCT only at their current price and subsidy.

A420205 - qA18036

Page 10 of 16

---

7.

Tenders awarded to listed pharmaceuticals where only the current brand is listed.

Presentation; Pack size and type Tab 2.5 mg; 500 tablet, bottle Tab 5 mg; 500 tablet, bottle Inj 50%, 10 ml; 5 ampoules Inj 50%, 90 ml; 1 bottle Cap 50 mg; 100 capsules, bottle Cap 120 mg; 100 capsules, bottle Oint BP 500 g; 500 g pot Tab 10 mg; 20 tablets, blister Crm 5%; 12 sachets Shampoo 2%; 100 ml, bottle Tab 135 mg; 90 tablets, blister Suppos 500 mg; 20 suppositories, blister Current pack price $7.58 New pack price $6.48 Hospital Supply Brand (Supplier) ArrowBendrofluazide (Arrow) ArrowBendrofluazide (Arrow) Biomed (Biomed) Biomed (Biomed) Laxofast 50 (Arrow) Laxofast 120 (Arrow) AFT (AFT) Gastrosoothe (AFT) Aldara (Douglas) Sebizole (Douglas) Colofac (Healthcare Logistics) Asacol (Baxter) DV Limit 1%

The decisions were as follows:

Chemical Name

Date of price change

Hospital Supply Status date

Bendrofluazide

1 July 2011

1 September 2011

Bendrofluazide

$11.75

$9.95

1%

1 July 2011

1 September 2011

Dextrose Dextrose Docusate sodium Docusate sodium Emulsifying ointment Hyoscine Nbutylbromide Imiquimod Ketoconazole Mebeverine hydrochloride Mesalazine

$22.75 $11.25 $3.95 $5.49 $3.69 $1.62 $110.40 $3.48

$19.50 $11.25 $2.57 $3.48 $3.04 $1.48 $62.00 $3.08

1% 1% 1% 1% 1% 1% 1% 1%

1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 September 2011 1 July 2011

1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 November 2011 1 September 2011

$18.00

$18.00

1%

1 July 2011

1 September 2011

$25.20

$22.80

1%

1 July 2011

1 September 2011

A420205 - qA18036

Page 11 of 16

---

Chemical Name Neostigmine Nystatin Pantoprazole Pergolide Pergolide Permethrin Poloxamer Ranitidine hydrochloride Ranitidine hydrochloride Ranitidine hydrochloride Tobramycin Triamcinolone acetonide Triamcinolone acetonide Triamcinolone acetonide

Presentation; Pack size and type Inj 2.5 mg per ml, 1 ml; 50 ampoules Oral liq 100,000 u per ml; 24 ml OP, bottle Inj 40 mg; 1 vial Tab 0.25 mg; 100 tablets, blister Tab 1 mg; 100 tablets, blister Lotion 5%; 30 ml, bottle Oral drops 10%; 30 ml OP, bottle Oral liq 150 mg per 10 ml; 300 ml, bottle Tab 150 mg; 250 tablets, bottle Tab 300 mg; 250 tablets, bottle Inj 40 mg per ml, 2 ml; 5 vials Crm 0.02%; 100 g, tube Oint 0.02%; 100 g, tube 0.1% in dental paste USP; 5 g, tube

Current pack price $150.00 $3.19 $8.75 $48.00 $170.00 $3.65 $3.78 $7.95 $7.99 $10.94 $34.50 $6.63 $6.69 $4.38

New pack price $140.00 $3.19 $6.50 $48.00 $170.00 $3.24 $3.78 $5.92 $6.79 $9.34 $29.32 $6.63 $6.69 $4.34

Hospital Supply Brand (Supplier) AstraZeneca (AstraZeneca) Nilstat (Sigma) Pantocid IV (API) Permax (Aspen) Permax (Aspen) A-Scabies (AFT) Coloxyl (Sigma) Peptisoothe (AFT) Arrow-Ranitidine (Arrow) Arrow-Ranitidine (Arrow) DBL Tobramycin (Hospira) Aristocort (Sigma) Aristocort (Sigma) Oracort (AFT)

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1%

Date of price change 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011 1 July 2011

Hospital Supply Status date 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011 1 September 2011

A420205 - qA18036

Page 12 of 16

---

Chemical Name Vancomycin hydrochloride

Presentation; Pack size and type Inj 500 mg; 1 vial

Current pack price $5.04

New pack price $3.58

Hospital Supply Brand (Supplier) Mylan (Mylan)

DV Limit 1%

Date of price change 1 July 2011

Hospital Supply Status date 1 September 2011

8.

Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

Presentation; Pack size and type Tab 100 mg; 1000 tablets, bottle Tab 300 mg; 500 tablets, bottle Tab 500 mg with potassium clavulanate 125 mg; 100 tablets, foil pack Tab 50 mg; 28 tablets, blister Tab 250 mg; 28 tablets, blister Tab 500 mg; 28 tablets, blister Tab 750 mg; 28 tablets, blister Tab 250 mg; 14 tablets, blister Current pack price $5.44 (per 250 tabs) $4.03 (per 100 tabs) $25.10 New pack price $15.90 (per 1,000 tabs) $16.75 (per 500 tabs) $12.55 Hospital Supply Brand (Supplier) Apo-Allopurinol (Apotex) Apo-Allopurinol (Apotex) Curam (Sandoz) Bicalaccord (Arrow) Cipflox (Mylan) Cipflox (Mylan) Cipflox (Mylan) DV Limit Date of listing/price change for tender winning brand 1 October 2011 Hospital Supply Status date (and delisting of other listed brands) 1 December 2011 Brand (Supplier) to be delisted Apo-Allopurinol* (Apotex) Apo-Allopurinol** (Apotex) Synermox (Douglas) Bicalox (Douglas) Rex Medical (Rex Medical) Rex Medical (Rex Medical) Rex Medical (Rex Medical) Klamycin (Mylan) Klacid (Abbott)

The decisions were as follows:

Chemical Name

Allopurinol

1%

Allopurinol

1%

1 October 2011

1 December 2011

Amoxycillin clavulanate Bicalutamide Ciprofloxacin Ciprofloxacin Ciprofloxacin

1%

1 November 2011

1 January 2012

$27.10 $3.35 $4.90 $7.54 $7.75

$10.00 $2.20 $3.00 $5.15

1% 1% 1% 1%

1 September 2011 1 September 2011 1 September 2011 1 September 2011

1 November 2011 1 November 2011 1 November 2011 1 November 2011

Clarithromycin

$5.53 (per 10 tabs)

$4.19 Apo-Clarithromycin (per 14 tabs) (Apotex)

1%

1 November 2011

1 January 2012

A420205 - qA18036

Page 13 of 16

---

Chemical Name

Presentation; Pack size and type Tab 500 mg; 14 tablets, blister Oint BP 100 g; 100 g pot Tab 5 mg; 30 tablets, blister Tab 250 mg; 28 tablets, blister Tab 7.5 mg; 30 tablets, bottle

Current pack price $23.30 $2.50 $19.20

New pack price $10.95 $1.95 $5.10

Hospital Supply Brand (Supplier) Apo-Clarithromycin (Apotex) Jaychem (Jaychem) Rex Medical (Rex Medical) Dr Reddy's Terbinafine (Dr Reddy’s) Apo-Zopiclone (Apotex)

DV Limit 1% 1% 1%

Date of listing/price change for tender winning brand 1 November 2011 1 September 2011 1 September 2011

Hospital Supply Status date (and delisting of other listed brands) 1 January 2012 1 November 2011 1 November 2011

Brand (Supplier) to be delisted Klamycin (Mylan) AFT (AFT) Fintral (Douglas) Apo-Terbinafine (Apotex) Apo-Zopiclone*** (Apotex)

Clarithromycin Emulsifying ointment Finasteride

Terbinafine

$25.50 $21.02 (per 500 tabs)

$3.57

1%

1 September 2011

1 November 2011

Zopiclone

$1.90

1%

1 July 2011

1 September 2011

* Apotex’s 250 tablet pack size will be delisted ** Apotex’s 100 tablet pack size will be delisted *** Apotex’s 500 tablet pack size will be delisted

A420205 - qA18036

Page 14 of 16

---

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2009/10 Invitation to Tender, dated 4 December 2009:

Chemical Name Bleomycin Inj 15,000 iu Line Item Chemical Name Pramipexole Tab 1.5 mg Line Item

The PHARMAC Board (or Chief Executive under Delegated Authority) resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2010/11 Invitation to Tender, dated 2 November 2010:

Chemical Name Alpha tocopheryl acetate Amiloride Amsacrine Ascorbic acid Betahistine dihydrochloride Betamethasone valerate Betamethasone valerate Calcipotriol Calcipotriol Chlorpheniramine maleate Chlorpheniramine maleate Desmopressin Desmopressin Diclofenac Dipyridamole Disulfiram Line Item Water solubilised soln 50 iu/ml - 156 iu/ml, with calibrated dropper Tab 5 mg Inj 75 mg Eye drops 10% Tab 16 mg Crm 0.1% Oint 0.1% Oint 50 mcg per g (pack size 30 g or less) Oint 50 mcg per g (pack size greater than 30 g) Inj 10 mg per ml Oral liq 2 mg per 5 ml Tab 100 mcg Tab 200 mcg Tab 50 mg dispersible Tab long-acting 200 mg Tab 200 mg Chemical Name Naproxen Naproxen Naproxen Naratriptan Nifedipine Nifedipine Nitrofurantoin Nitrofurantoin Nitrofurantoin Noradrenaline acid tartrate Nortriptyline hydrochloride Nortriptyline hydrochloride Nortriptyline hydrochloride Orphenadrine citrate Pilocarpine Piroxicam Line Item Oral liq 25 mg per ml Tab long-acting 1,000 mg Tab long-acting 750 mg Tab 2.5 mg Cap 10 mg Cap 5 mg Oral liq 25 mg per 5 ml Tab 100 mg Tab 50 mg Inj 2 mg per ml (1 mg noradrenaline per ml) Oral liq 10 mg per 5 ml Tab 10 mg Tab 25 mg Tab 100 mg Eye drops 2% single dose Tab dispersible 10 mg

A420205 - qA18036

Page 15 of 16

---

Chemical Name Doxycycline hydrochloride Erythromycin ethyl succinate Erythromycin ethyl succinate Erythromycin lactobionate Filgrastim Filgrastim Filgrastim Fluconazole Glycerol Granisetron Hydrochlorothiazide Hydrochlorothiazide Labetalol Levofloxacin Lorazepam Lorazepam Melphalan Melphalan Metronidazole Midazolam Tab 50 mg

Line Item

Chemical Name Piroxicam Pravastatin Quinapril with hydrochlorothiazide Quinapril with hydrochlorothiazide Thiamine hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Tramadol hydrochloride Ziprasidone Ziprasidone Ziprasidone Ziprasidone Zolmitriptan Zolmitriptan

Line Item Tab dispersible 20 mg Tab 80 mg Tab 10 mg with hydrochlorothiazide 12.5 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Inj 100 mg per ml, 2 ml Oral liq 100 mg per ml Tab sustained release 50 mg Tab sustained release 100 mg Tab sustained release 150 mg Tab sustained release 200 mg Tab sustained release 300 mg Tab sustained release 400 mg Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 2 ml Tab 20 mg Tab 40 mg Tab 60 mg Tab 80 mg Tab 2.5 mg Tab 5 mg

Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Inj 1 g Inj 300 mcg per ml Inj 480 mcg per ml Inj 300 mcg per ml Oral liquid Suppos 3 g or less Tab 1 mg Tab 12.5 mg Tab 25 mg Tab 400 mg Tab 500 mg Inj 2 mg per ml Inj 4 mg per ml Inj 50 mg Tab 2 mg Inf 500 mg per 100 ml Tab 7.5 mg

For products included in the 2008/09 Invitation to Tender, 2009/10 Invitation to Tender and 2010/11 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A420205 - qA18036 Page 16 of 16